You have access
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours
NICOLA FAZIO, ROBERTO BUZZONI, ERIC BAUDIN, LORENZO ANTONUZZO, RICHARD A. HUBNER, HARALD LAHNER, WOUTER W. DE HERDER, MARKUS RADERER, ALEXANDRE TEULÉ, JAUME CAPDEVILA, STEVEN K. LIBUTTI, MATTHEW H. KULKE, MANISHA SHAH, DEBARSHI DEY, SABINE TURRI, PAOLA AIMONE, CRISTIAN MASSACESI and CHRIS VERSLYPE
Anticancer Research February 2016, 36 (2) 713-719;